Compare TWO & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TWO | NEO |
|---|---|---|
| Founded | 2009 | 2001 |
| Country | United States | United States |
| Employees | 486 | N/A |
| Industry | Real Estate Investment Trusts | Precision Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | N/A | 2008 |
| Metric | TWO | NEO |
|---|---|---|
| Price | $12.52 | $9.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $12.56 | ★ $13.38 |
| AVG Volume (30 Days) | ★ 2.4M | 2.0M |
| Earning Date | 04-28-2026 | 04-28-2026 |
| Dividend Yield | ★ 11.77% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | N/A | $9.73 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.84 | $4.72 |
| 52 Week High | $14.17 | $13.74 |
| Indicator | TWO | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 66.49 | 60.46 |
| Support Level | $9.75 | $7.42 |
| Resistance Level | $12.70 | $10.82 |
| Average True Range (ATR) | 0.13 | 0.40 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 56.90 | 89.45 |
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, residential mortgage loans, mortgage servicing rights, and commercial real estate. The majority of its investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. The company derives revenues mainly from its MSR and Agency RMBS portfolio, including servicing fee income, float income, and interest income, as well as mortgage loan origination activities established to support the MSR portfolio. Its investment portfolio is subject to market risks, mainly interest rate, basis, and prepayment risk. The majority of income is generated by available-for-sale securities.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.